ELI-002

N/A

Report date: 2025/11/10 15:23:38

Base Information

Drug NameELI-002
Drug Alias NameAMP KRASAmph-CpG-7909Amphiphile mKRAS vaccineAmph-CpG-7909ELI-002 +[7] 
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog modulators
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumoursNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesElicio Therapeutics
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A